Green Thumb Industries (OTCMKTS:GTBIF) Sets New 52-Week High at $16.33

Green Thumb Industries Inc. (OTCMKTS:GTBIF - Get Free Report)'s stock price hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $16.33 and last traded at $15.35, with a volume of 2164667 shares trading hands. The stock had previously closed at $12.55.

Analysts Set New Price Targets

Separately, Needham & Company LLC boosted their price objective on Green Thumb Industries from $11.00 to $15.50 and gave the company a "buy" rating in a research note on Thursday, February 29th.

Green Thumb Industries Trading Up 22.3 %

The company has a market capitalization of $3.23 billion, a P/E ratio of 102.33 and a beta of 1.67. The stock has a 50 day moving average of $13.14 and a 200-day moving average of $11.77.

Green Thumb Industries (OTCMKTS:GTBIF - Get Free Report) last posted its quarterly earnings results on Wednesday, February 28th. The company reported $0.01 earnings per share for the quarter, missing the consensus estimate of $0.05 by ($0.04). Green Thumb Industries had a return on equity of 2.13% and a net margin of 3.44%. The business had revenue of $278.23 million during the quarter, compared to the consensus estimate of $270.07 million. As a group, sell-side analysts expect that Green Thumb Industries Inc. will post 0.26 EPS for the current fiscal year.

About Green Thumb Industries

Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.